- The next generation recombinant human cytomegalovirus vaccine candidates-beyond gBAnders E Lilja
Novartis Vaccines and Diagnostics, Inc, Cambridge, MA 02139, United States
Vaccine 30:6980-90. 2012..These data show the clinical feasibility of a recombinant HCMV vaccine. We discuss areas for potential improvements in the next generation of vaccine candidates...
- Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggsPirada Suphaphiphat
Novartis Vaccines and Diagnostics, Cambridge, MA, USA
Virol J 7:157. 2010..Thus, we have demonstrated that molecular cloning of members of a quasispecies can help in selection of seed viruses for vaccine manufacture...